Japan Distribution AgreementJapan Distribution Agreement • December 10th, 2004 • Conor Medsystems Inc • Surgical & medical instruments & apparatus • New York
This Distributor Agreement (“Agreement”) is made effective as of this 19th day of November, 2004 between Conor Medsystems Ireland, Ltd. (“Supplier”), an Irish corporation, having offices at 30 Herbert Street, Dublin 2, Ireland and Getz Bros. Co., Ltd., (“Distributor”), a Japanese corporation, located at Avex Building 4F, 3-1-30 Minami-Aoyama, Minato-ku, Tokyo 107-0062, Japan.
CONOR MEDSYSTEMS, INC. [ ] Shares1 Common Stock ($0.001 par value) UNDERWRITING AGREEMENTUnderwriting Agreement • December 10th, 2004 • Conor Medsystems Inc • Surgical & medical instruments & apparatus • New York
Australia Distribution AgreementAustralia Distribution Agreement • December 10th, 2004 • Conor Medsystems Inc • Surgical & medical instruments & apparatus • New York
This Distributor Agreement (“Agreement”) is made effective as of this 19th day of November, 2004 between Conor Medsystems Ireland, Ltd. (“Supplier”), an Irish corporation, having offices at 30 Herbert Street, Dublin 2, Ireland and St. Jude Medical Australia Pty Ltd. (“Distributor”), a Victoria corporation, located at Level One, 290 Burns Bay Road, Lane Cove NSW 2066, Australia.
INTERNATIONAL DISTRIBUTION AGREEMENT BETWEEN CONOR MEDSYSTEMS, INC. AND INTERVENTIONAL TECHNOLOGIES PVT., LTD.International Distribution Agreement • December 10th, 2004 • Conor Medsystems Inc • Surgical & medical instruments & apparatus • California
THIS INTERNATIONAL DISTRIBUTION AGREEMENT (the “Agreement”) is made and entered into as of July 1, 2004, by and between CONOR MEDSYSTEMS IRELAND, LTD., an Irish corporation having its offices at 30 Herbert Street, Dublin 2, Ireland (“Conor”), and INTERVENTIONAL TECHNOLOGIES, PVT., LTD., an Indian corporation having its offices in Mumbai, India 201, Steel House, 2nd Floor 24, Mahal Industrial Estate, Mahakali Caves Road, Andheri(E) Mumbai-400 093 (the “Distributor”).
Distribution AgreementDistribution Agreement • December 10th, 2004 • Conor Medsystems Inc • Surgical & medical instruments & apparatus • New York
This document and all the information contained herein are the Confidential Information (as defined herein) of each of BIOTRONIK AG and Conor Medsystems Ireland, Ltd.
COLLABORATIVE LICENSE AND SUPPLY AGREEMENTCollaborative License and Supply Agreement • December 10th, 2004 • Conor Medsystems Inc • Surgical & medical instruments & apparatus • California
THIS COLLABORATIVE LICENSE AND SUPPLY AGREEMENT (“Agreement”) is entered into this 4th day of April, 2003, and shall be effective as of the date of the last signature below (the “Effective Date”) by and between CONOR MEDSYSTEMS, INC. (“Conor”), a Delaware corporation, with offices at 1360 Willow Road, Second Floor, Menlo Park, California 94025 and PHYTOGEN INTERNATIONAL LLC (“Phytogen”), a limited liability company existing under the laws of Wyoming, having its principal office at First Floor, Unit 41, The Business Centre, Stadium Business Park, Ballycoolin, Dublin 11, Ireland.
Korea Distribution AgreementKorea Distribution Agreement • December 10th, 2004 • Conor Medsystems Inc • Surgical & medical instruments & apparatus • New York
This Distributor Agreement (“Agreement”) is made effective as of this 19th day of November, 2004 between Conor Medsystems Ireland, Ltd. (“Supplier”), an Irish corporation, having offices at 30 Herbert Street, Dublin 2, Ireland and St. Jude Medical (Hong Kong) Limited (“Distributor”), a Hong Kong, SAR corporation, located at 2708 China Merchants Tower, Shun Tak Centre, 168-200 Connaught Road, Central, Hong Kong, SAR, People’s Republic of China.
Conor Letterhead]Conor Medsystems Inc • December 10th, 2004 • Surgical & medical instruments & apparatus
In connection with the execution and delivery of that certain Underwriting Agreement, dated as of December , 2004, by and among you, as the Selling Stockholder, Conor Medsystems, Inc. (the “Company”) and the Underwriters named therein, a copy of which is attached as Exhibit A hereto (the “Underwriting Agreement”), the Company has agreed to provide you with the following indemnification rights:
